<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Amino acid levels</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Amino acid levels</h1>
<div class="graphic"><div class="figure"><div class="ttl">Amino acid levels</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Amino acid</td> <td class="subtitle1">High in plasma</td> <td class="subtitle1">Low in plasma</td> <td class="subtitle1">High in urine</td> </tr> <tr> <td>Alanine</td> <td>Disorders of pyruvate metabolism, urea cycle disorders, mitochondrial disorders</td> <td>Untreated maple syrup urine disease</td> <td>Disorders of pyruvate metabolism, urea cycle disorders, mitochondrial disorders</td> </tr> <tr> <td>Alloisoleucine</td> <td>Maple syrup urine disease</td> <td>–</td> <td>Maple syrup urine disease</td> </tr> <tr> <td>Arginine</td> <td>Argininemia</td> <td>Argininosuccinic aciduria, citrullinemia, ornitine transcarbamylase deficiency, carbamylphosphatase deficiency, inadequate diet</td> <td>Argininemia, cystinuria, lysinuric protein intolerance</td> </tr> <tr> <td>Argininosuccinate</td> <td>Argininosuccinic aciduria</td> <td>–</td> <td>Argininosuccinic aciduria</td> </tr> <tr> <td>Aspartate</td> <td>–</td> <td>–</td> <td>–</td> </tr> <tr> <td>Citrulline</td> <td>Citrullinemia, citrin deficiency, argininosuccinic aciduria</td> <td>Ornitine transcarbamylase deficiency, carbamylphosphatase deficiency, inadequate diet</td> <td>Citrullinemia, citrin deficiency, argininosuccinic aciduria</td> </tr> <tr> <td>Cystine</td> <td>–</td> <td>Molybdenum cofactor deficiency/sulfate oxidase deficiency</td> <td>Cystinuria</td> </tr> <tr> <td>Glutamate</td> <td>Improper sample handling</td> <td>–</td> <td>–</td> </tr> <tr> <td>Glutamine</td> <td>Urea cycle disorders/hyperammonemia</td> <td>Improper sample handling</td> <td>–</td> </tr> <tr> <td>Glycine</td> <td>Glycine encephalopathy, organic acidemias</td> <td>–</td> <td>Glycine encephalopathy, organic acidemias</td> </tr> <tr> <td>Histidine</td> <td>Histidinemia (benign condition)</td> <td>–</td> <td>Histidinemia (benign condition)</td> </tr> <tr> <td>Homocystine (free)</td> <td>Homocystinuria, disorders of vitamin B12 transport and synthesis</td> <td>–</td> <td>Cystathionine beta-synthetase deficiency, disorders of vitamin B12 transport and synthesis</td> </tr> <tr> <td>Isoleucine</td> <td>Maple syrup urine disease, fasting</td> <td>–</td> <td>Maple syrup urine disease</td> </tr> <tr> <td>Leucine</td> <td>Maple syrup urine disease, fasting</td> <td>–</td> <td>Maple syrup urine disease</td> </tr> <tr> <td>Lysine</td> <td>Citrin deficiency, hyperlysinemia (benign)</td> <td>–</td> <td>Cystinuria, lysinuric protein intolerance</td> </tr> <tr> <td>Methionine</td> <td>Homocystinuria, citrin deficiency, liver dysfunction</td> <td>Disorders of vitamin B12 transport and synthesis</td> <td>Cystathionine beta-synthetase deficiency, liver dysfunction</td> </tr> <tr> <td>Ornithine</td> <td>Ornitine aminotransferase deficiency, hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome</td> <td>–</td> <td>Cystinuria, lysinuric protein intolerance, ornithine aminotransferase deficiency</td> </tr> <tr> <td>Phenylalanine</td> <td>Phenylketonuria</td> <td>–</td> <td>Phenylketonuria</td> </tr> <tr> <td>Proline</td> <td>Hyperprolinemia</td> <td>–</td> <td>Hyperprolinemia</td> </tr> <tr> <td>Serine</td> <td>–</td> <td>3-phosphoglycerate dehydrogenase deficiency</td> <td>–</td> </tr> <tr> <td>Threonine</td> <td>Citrin deficiency</td> <td>–</td> <td>–</td> </tr> <tr> <td>Tryptophan</td> <td>–</td> <td>–</td> <td>–</td> </tr> <tr> <td>Tyrosine</td> <td>Tyrosinemia types I and II, hepatic dysfunction</td> <td>Phenylketonuria</td> <td>Tyrosinemia types I and II, hepatic dysfunction</td> </tr> <tr> <td>Valine</td> <td>Maple syrup urine disease, fasting</td> <td>–</td> <td>Maple syrup urine disease</td> </tr> </tbody></table></div><div class="graphic_lgnd"><strong>Patterns of abnormalities:</strong><br/><ul>
<li>Argininemia - elevated plasma arginine</li>
<li>Argininosuccinic aciduria - elevated plasma citrulline, elevated plasma argininosuccinate, low plasma arginine</li>
<li>Carbamyl phosphate synthetase deficiency - low plasma citrulline, ±elevated plasma glutamine (identical pattern to ornithine transcarbamylase deficiency)</li>
<li>Citrin deficiency - elevated plasma citrulline, threonine, methionine, lysine, and arginine</li>
<li>Citrullinemia - elevated plasma citrulline, low plasma arginine</li>
<li>Cystinuria - elevated urine cystine, lysine, arginine, and ornithine</li>
<li>Glycine encephalopathy - cerebrospinal fluid (CSF):plasma glycine ratio &gt;0.08</li>
<li>HHH syndrome - elevated plasma ornithine</li>
<li>Homocystinuria - elevated plasma homocystine* and methionine</li>
<li>Hyperprolinemia - elevated plasma proline</li>
<li>Lysinuric protein intolerance - elevated urine lysine, arginine, and ornithine</li>
<li>Maple syrup urine disease - elevated plasma alloisoleucine, isoleucine, leucine, and valine with perturbation of the normal 1:2:3 ratio of isoleucine:leucine:valine, low plasma alanine</li>
<li>Ornithine aminotransferase deficiency - elevated plasma ornithine</li>
<li>Ornithine transcarbamylase deficiency - low plasma citrulline, ± elevated plasma glutamine (identical pattern to carbamyl phosphate synthetase deficiency)</li>
<li>Phenylketonuria - elevated plasma phenylalanine ± low plasma tyrosine</li>
<li>Tyrosinemia types I and II - elevated plasma tyrosine</li>
<li>Vitamin B12 (cobalamin) processing disorders - elevated plasma homocystine* with low or normal plasma methionine</li></ul></div><div class="graphic_footnotes">* Routine plasma amino acid analysis measures free plasma homocystine, not total plasma homocystine. Total plasma homocystine is the preferred test for the diagnosis and management of homocystinuria and disorders of vitamin B12 (cobalamin) transport and synthesis.</div><div class="graphic_reference">Courtesy of V Reid Sutton, MD.</div><div id="graphicVersion">Graphic 73440 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
